Form 4: Grace Therapeutics Insider Buys Shares
Insider Transaction (Form 4)
Opaleye Management Inc. reported changes in beneficial ownership of Grace Therapeutics, Inc. common stock on October 14, 2026.
Summary
- Open-market purchase: acquired 11,233 Common Stock, par value $0.0001 per share at $1.93 ($21,735) on October 14, 2026; holds 2,884,522 after (Indirect).
- Open-market purchase: acquired 23,485 Common Stock, par value $0.0001 per share at $1.95 ($45,685) on October 15, 2026; holds 2,908,007 after (Indirect).
- Open-market purchase: acquired 36,347 Common Stock, par value $0.0001 per share at $1.89 ($68,758) on October 16, 2026; holds 2,944,354 after (Indirect).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $136,178, committing personal capital to the stock.
Insider Transactions
Opaleye Management Inc. — 10% owner
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-14 | Open-market purchase | Common Stock, par value $0.0001 per share | 11,233 | $2 | $21.7K | 2,884,522 |
| 2026-10-15 | Open-market purchase | Common Stock, par value $0.0001 per share | 23,485 | $2 | $45.7K | 2,908,007 |
| 2026-10-16 | Open-market purchase | Common Stock, par value $0.0001 per share | 36,347 | $2 | $68.8K | 2,944,354 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-14 | Open-market purchase (11,233 shares) |
| 2026-10-15 | Open-market purchase (23,485 shares) |
| 2026-10-16 | Open-market purchase (36,347 shares) |
Keywords
insider transaction, Form 4, GRCE, Grace Therapeutics, Inc., bullish, Opaleye Management Inc.
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.